Antonio Izzi, Giuseppe Mincolelli, Grazia D'Onofrio, Vincenzo Marchello, Aldo Manuali, Nadia Icolaro, Lucia Mirabella, Anna Riefolo, Barbara Mazzotta, Alessio Barile, Leonardo Pio Gorgoglione, Alfredo Del Gaudio
BACKGROUND: In Awake Craniotomy (AC), α2-agonists and remifentanil (clonidine and dexmedetomidine) are used in the preoperative phase and throughout the procedure to combine monitored anesthesia care and local anesthesia. The study aims were to specify the key role of α2-agonists administered and to evaluate complication presence/absence in anesthesiologic management. METHODS: 42 patients undergoing AC in 3 different centers in the south of Italy (Foggia, San Giovanni Rotondo, and Bari) were recruited...
January 30, 2024: Brain Sciences